Back to Search
Start Over
Unique Molecular Landscapes in Cancer: Implications for Individualized, Curated Drug Combinations.
- Source :
-
Cancer Research . 12/15/2014, Vol. 74 Issue 24, p7181-7184. 4p. - Publication Year :
- 2014
-
Abstract
- With increasingly sophisticated technologies in molecular biology and "omic" platforms to analyze patients' tumors, more molecular diversity and complexity in cancer are being observed. Recently, we noted unique genomic profiles in a group of patients with metastatic breast cancer based on an analysis with nextgeneration sequencing. Among 57 consecutive patients, no two had the same molecular portfolio. Applied genomics therefore appears to represent a disruptive innovation in that it unveils a heterogeneity to metastatic cancer that may be ill-suited to canonical clinical trials and practice paradigms. Upon recognizing that patients have unique tumor landscapes, it is possible that there may be a "mismatch" between our traditional clinical trials system that selects patients based on common characteristics to evaluate a drug (drug-centric approach) and optimal treatment based on curated, individualized drug combinations for each patient (patient-centric approach). [ABSTRACT FROM AUTHOR]
- Subjects :
- *MOLECULAR biology
*TUMORS
*CANCER research
*BREAST cancer research
*METASTASIS
Subjects
Details
- Language :
- English
- ISSN :
- 00085472
- Volume :
- 74
- Issue :
- 24
- Database :
- Academic Search Index
- Journal :
- Cancer Research
- Publication Type :
- Academic Journal
- Accession number :
- 100052354
- Full Text :
- https://doi.org/10.1158/0008-5472.CAN-14-2329